Cyclacel Pharmaceuticals IncHere is the public summary page for Cyclacel Pharmaceuticals Inc. Please login to see the complete information for Cyclacel Pharmaceuticals Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Cyclacel Pharmaceuticals Inc stacks up relative to its peers. |
| Darwin Score | -26 |
| Ticker | CYCC |
| Latest Price | 16.04 USD as of close on 25-Jul-2025 |
| 3 Month price range | 3.31 to 84.96 USD |
| Market Capitalisation | 27.16Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia. See More ... |
| Company URL | https://www.cyclacel.com |
| See Darwins Full Analysis for Cyclacel Pharmaceuticals Inc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Cyclacel Pharmaceuticals Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +1 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -10 |
| Flow | Institutional, Fund and Insider buying and selling. | +1 |
| Models | Forecast models. | -17 |
Alerts
There are 12 live alerts for Cyclacel Pharmaceuticals Inc.
- Overbought - The 15 day RSI is +73.9. (Negative)
- Oversold - The 15 month RSI is +25.7. (Positive)
- High Volume 2x 65dma. This alert has occurred 42 times over the last last year. The average forward returns are -11.3% over 5 days, -29.4% over 10 days, -45.0% over 15 days and -40.6% over 20 days. (Positive)
- 15d RSI Overbought. This alert has occurred 12 times over the last last year. The average forward returns are -18.6% over 5 days, -49.7% over 10 days, -57.9% over 15 days and -61.0% over 20 days. (Positive)
- Breakup Trigger s-t. This alert has occurred 6 times over the last last year. The average forward returns are -0.7% over 5 days, -29.2% over 10 days, -48.3% over 15 days and -54.4% over 20 days. (Positive)
- New High (1m). This alert has occurred 7 times over the last last year. The average forward returns are -7.9% over 5 days, -34.9% over 10 days, -51.3% over 15 days and -57.3% over 20 days. (Positive)
- Technically Overbought - 14 day RSI above 70. This alert has occurred 13 times over the last last year. The average forward returns are -7.8% over 5 days, -40.8% over 10 days, -54.1% over 15 days and -58.2% over 20 days. (Positive)
- High Volume 2x 130dma. This alert has occurred 43 times over the last last year. The average forward returns are -16.0% over 5 days, -34.3% over 10 days, -45.9% over 15 days and -32.1% over 20 days. (Positive)
- Overbought - The 5 week RSI is +74.2. (Negative)
- Candle Pattern :: Doji (Positive) (Positive)
- Divergence: Px Down & OBV Up last 65 days. This alert has occurred 225 times over the last last year. The average forward returns are -2.6% over 5 days, -4.6% over 10 days, -6.7% over 15 days and -6.4% over 20 days. (Positive)
- 5d RSI Overbought. This alert has occurred 30 times over the last last year. The average forward returns are -0.9% over 5 days, -18.5% over 10 days, -29.6% over 15 days and -32.4% over 20 days. (Positive)
Peer Comparison
There are 27 peers of Cyclacel Pharmaceuticals Inc.
Share 
